Cargando…

New Therapeutic Target for Pulmonary Arterial Hypertension

Detalles Bibliográficos
Autor principal:	Yoon, Kyung Lim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221863/ https://www.ncbi.nlm.nih.gov/pubmed/30403018 http://dx.doi.org/10.4070/kcj.2018.0250

Ejemplares similares

Udenafil as a Therapeutic Option for Pulmonary Arterial Hypertension
por: Kim, Hyung Yoon, et al.
Publicado: (2019)

New horizons in pulmonary arterial hypertension management
por: McLaughlin, Vallerie, et al.
Publicado: (2014)

Atrial Septal Defect with Down Syndrome and Postsurgical Pulmonary Hypertension
por: Yoon, Kyung Lim
Publicado: (2019)

Pulmonary Hypertension: Unveiling Molecular Mechanisms, Diagnosis, and Therapeutic Targets
por: Gredic, Marija, et al.
Publicado: (2023)

What is pulmonary arterial hypertension?
por: Rich, Stuart
Publicado: (2012)

The revolution of pulmonary arterial hypertension
por: Harari, Sergio
Publicado: (2016)

Identification of Novel Therapeutic Targets for Pulmonary Arterial Hypertension
por: Satoh, Kimio, et al.
Publicado: (2018)

Potassium Channels as Therapeutic Targets in Pulmonary Arterial Hypertension
por: Redel-Traub, Gabriel, et al.
Publicado: (2022)

Illuminating the Importance of Pulmonary Arterial Compliance in Pulmonary Hypertension
por: Weatherald, Jason, et al.
Publicado: (2023)

Targeting Vessel Formation in Pulmonary Arterial Hypertension: Is the Endostatin–Id1–Thrombospondin 1 Pathway a New Hope?
por: Rhodes, Christopher J.
Publicado: (2020)

Right Ventricular Longitudinal Strain: A Target Indicator in the Treatment of Pulmonary Arterial Hypertension
por: Cho, Kyoung Im
Publicado: (2015)

Targeting L-arginine-nitric oxide-cGMP pathway in pulmonary arterial hypertension
por: Tang, Haiyang, et al.
Publicado: (2017)

A Plot TWIST in Pulmonary Arterial Hypertension
por: Misner, Kevin, et al.
Publicado: (2020)

Deconstructing the Melting Pot in Pulmonary Arterial Hypertension
por: Austin, Eric D., et al.
Publicado: (2020)

Iron deficiency in pulmonary arterial hypertension: perspectives
por: Quatredeniers, Marceau, et al.
Publicado: (2021)

Targeting Neurohormonal Activation in Pulmonary Arterial Hypertension: Putting the Puzzle Together
por: Gomez-Arroyo, Jose, et al.
Publicado: (2017)

Is VEGF a new therapeutic target for hypertension in chronic kidney disease?
por: Kim, Yon Su
Publicado: (2013)

Potential therapeutic targets for hypoxia-induced pulmonary artery hypertension
por: Dong, Li, et al.
Publicado: (2014)

Potential biomarkers and therapeutic targets of idiopathic pulmonary arterial hypertension
por: He, Wenjun, et al.
Publicado: (2022)

New Tricks for an Old Drug: Prostacyclins and Right Ventricular Contractility in Pulmonary Arterial Hypertension
por: Wertheim, Bradley M.
Publicado: (2022)

Does hypertension begin in adolescence?
por: Yoon, Kyung Lim
Publicado: (2013)

New Therapeutic Paradigms and Guidelines in the Management of Pulmonary Arterial Hypertension
por: Hill, Nicholas S., et al.
Publicado: (2016)

Quality of life in pulmonary arterial hypertension
por: Post, M.C., et al.
Publicado: (2015)

Pulmonary arterial hypertension in adults with atrial septal defect
por: Toyono, Manatomo
Publicado: (2012)

A Novel Peptide for Immunomodulation in Pulmonary Arterial Hypertension
por: Grinnan, Daniel, et al.
Publicado: (2019)

Pulmonary arterial hypertension in scleroderma: care gaps in screening
por: Pope, Janet E.
Publicado: (2017)

Pulmonary arterial hypertension registries: past, present and into the future
por: Weatherald, Jason, et al.
Publicado: (2019)

Role of Ion Channels in the Development of Pulmonary Arterial Hypertension
por: Antigny, Fabrice
Publicado: (2022)

A paradigm shift in pulmonary arterial hypertension management
por: Rubin, Lewis J., et al.
Publicado: (2013)

Promises and Pitfalls of Multiomics Approaches to Pulmonary Arterial Hypertension
por: Simpson, Catherine E., et al.
Publicado: (2022)

Revisiting the Role of KCNA5 in Pulmonary Arterial Hypertension
por: Ayon, Ramon J., et al.
Publicado: (2023)

Borderline pulmonary pressures in scleroderma - a ‘pre-pulmonary arterial hypertension’ condition?
por: Kovacs, Gabor, et al.
Publicado: (2015)

Targeting BMPR2 Trafficking with Chaperones: An Important Step toward Precision Medicine in Pulmonary Arterial Hypertension
por: Andruska, Adam, et al.
Publicado: (2020)

Interleukin-6 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension
por: Furuya, Yoshiaki, et al.
Publicado: (2010)

CD248 as a novel therapeutic target in pulmonary arterial hypertension
por: Xu, Tao, et al.
Publicado: (2020)

Sex Hormones across the Menstrual Cycle in Pulmonary Arterial Hypertension: Adding a New Layer of Complexity
por: Austin, Eric D.
Publicado: (2021)

Benefits from the Early Initiation of Macitentan for Pulmonary Arterial Hypertension
por: Jung, Hae Ok
Publicado: (2018)

Pregnancy in Patients with Pulmonary Arterial Hypertension “To Deliver, or Not to Deliver: That Is the Question”
por: Park, Jae-Hyeong
Publicado: (2019)

Early Diagnosis in Pulmonary Arterial Hypertension: The Search for the Holy Grail
por: Berger, Rolf M. F., et al.
Publicado: (2019)

End Stage Takes Center Stage in Pulmonary Arterial Hypertension
por: Hamid, Rizwan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pllje150cr2ntu0mug6e03vdjs